Frontiers | Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy - ScienceDirect
Identification of Host Proteins Involved in Japanese Encephalitis Virus Infection by Quantitative Proteomics Analysis | Journal of Proteome Research
Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells | Communications Biology
Cancers | Free Full-Text | Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance
Frontiers | Microglia Heterogeneity in Alzheimer's Disease: Insights From Single-Cell Technologies
Flow Assisted Mutation Enrichment (FAME): A highly efficacious and efficient method to enrich Double Knockouts (DKO) after gene editing | PLOS ONE
Frontiers | Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
IJMS | Free Full-Text | MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
Microglia coordinate cellular interactions during spinal cord repair in mice | Nature Communications
FcRn colocalizes with an ER marker in the absence of β2m. FO-1... | Download Scientific Diagram
Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease - ScienceDirect
Beta-2 microglobulin - Wikipedia
IJMS | Free Full-Text | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy | Scientific Reports
A novel role for β2-microglobulin: a precursor of antibacterial chemokine in respiratory epithelial cells | Scientific Reports
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis - Atherosclerosis
Frontiers | HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
IJMS | Free Full-Text | Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
The order and logic of CD4 versus CD8 lineage choice and differentiation in mouse thymus | Nature Communications
IJMS | Free Full-Text | The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Cancers | Free Full-Text | Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer
